Cell-Surface Integrins and CAR Are Both Essential for Adenovirus Type 5 Transduction of Canine Cells of Lymphocytic Origin

• Published in: PloS one 2017-01, Vol.12 (1), p.e0169532-e0169532
• Main Authors: Agarwal, Payal, Gammon, Elizabeth A, Sajib, Abdul Mohin, Sandey, Maninder, Smith, Bruce F
• Format: Article
• Language: English
• Subjects: Adenoviridae; Adenoviruses; Adenoviruses, Human - physiology; Animals; Binding; Biology; Biology and Life Sciences; Cancer; Cell culture; Cell Line; Cell surface; Coxsackie and Adenovirus Receptor-Like Membrane Protein - genetics; Coxsackie and Adenovirus Receptor-Like Membrane Protein - metabolism; Dogs; Enterovirus; Expression vectors; Gene Expression; Gene therapy; Genes, Reporter; Genetic aspects; Genomes; Health aspects; Humans; Infections; Integrins; Integrins - genetics; Integrins - metabolism; Internalization; Kinases; Laboratory animals; Leukemia; Lymphocytes - metabolism; Lymphocytes - virology; Lymphoma; Medicine and Health Sciences; Melanoma; Myeloid cells; Penicillin; Peripheral blood mononuclear cells; Physiological aspects; Picornaviridae; Polymerase chain reaction; Research and Analysis Methods; RNA, Messenger - genetics; RNA, Messenger - metabolism; RNA-directed DNA polymerase; Transcription; Transduction, Genetic; Tumor cell lines; Tumors; Vectors (Biology); Veterinary colleges; Veterinary medicine; Virology; Viruses
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0169532

Adenoviruses are the most widely used vectors in cancer gene therapy. Adenoviruses vectors are well characterized and are easily manipulated. Adenovirus serotype 5 (Ad5) is the most commonly used human serotype. Ad5 internalization into host cells is a combined effect of binding of Ad5 fiber knob with the coxsackie virus and adenovirus receptor (CAR) and binding of RGD motifs in viral penton to cell surface integrins (αvβ3, αvβ5). Ad5's wide range of host-cell transduction and lack of integration into the host genome have made it an excellent choice for cancer therapeutics. However, Ad5 has limited ability to transduce cells of hematopoietic origin. It has been previously reported that low or no expression of CAR is a potential obstacle to Ad5 infection in hematopoietic origin cells. In addition, we have previously reported that low levels of cell surface integrins (αvβ3, αvβ5) may inhibit Ad5 infection in canine lymphoma cell lines. In the current report we have examined the ability of an Ad5 vector to infect human (HEK293) and canine non-cancerous (NCF and PBMC), canine non-hematopoietic origin cancer (CMT28, CML7, and CML10), and canine hematopoietic origin cancer (DH82, 17-71, OSW, MPT-1, and BR) cells. In addition, we have quantified CAR, αvβ3 and αvβ5 integrin transcript expression in these cells by using quantitative reverse transcriptase PCR (q-RT-PCR). Low levels of integrins were present in MPT1, 17-71, OSW, and PBMC cells in comparison to CMT28, DH82, and BR cells. CAR mRNA levels were comparatively higher in MPT1, 17-71, OSW, and PBMC cells. This report confirms and expands the finding that low or absent expression of cell surface integrins may be the primary reason for the inability of Ad5-based vectors to transduce cells of lymphocytic origin and some myeloid cells but this is not true for all hematopoietic origin cells. For efficient use of Ad5-based therapeutic vectors in cancers of lymphocytic origin, it is important to address the defects in cell surface integrins.